EPIC

What this means for you

Registered since 31 Dec 2024. The owner can stop confusingly similar uses in the classes it covers.

Record

Serial number

97642362

Registration number

7629331

Mark type

Stylized text

Filed

21 Oct 2022

Published for opposition

12 Mar 2024

Registered

31 Dec 2024

Attorney of record

Michael J. Leonard

Goods and services

• Class 001 — Chemicals: Human immune cells, in particular T cells, for scientific and medical research
• Class 005 — Pharmaceuticals: Chemical, biological and biochemical preparations and reagents for the cultivation of human immune cells, in particular T cells, for medical purposes in the treatment of immuno-oncological diseases; Human immune cells, in particular T cells, for medical or clinical purposes; biological preparations and pharmaceutical compositions containing human immune cells, in particular T cells for the treatment of immuno-oncological diseases; biological preparations and pharmaceutical preparations for use in medical and clinical cell therapy, in particular immune cell therapy, in particular T cell therapy; biological preparations and pharmaceutical composition containing human immune cells, in particular T-cells, for the treatment of inflammatory diseases, diseases of the immune system and cancer; biological preparations and pharmaceutical preparations containing human immune cells, in particular T-cells, for the treatment of inflammatory diseases, diseases of the immune system and cancer; biological preparations and pharmaceutical preparations in the form of living cells for use in the treatment of immuno-oncological diseases
• Class 040 — Treatment of materials: Contract manufacturing of therapeutic medicinal products, namely, Contract manufacturing of cell therapies for the treatment of inflammatory diseases, diseases of the immune system and cancer; Contract manufacturing for others, in particular manufacturing of pharmaceutical preparations for health care, for the treatment of people suffering from diseases treated by cell therapy or regenerative medicine products, namely, medicinal products for human use including investigational medicinal products, investigational biological products, cell therapy preparations and advanced therapy medicinal products, all of the foregoing not in connection with medical diagnostics, cancer diagnostics and cancer profiling
• Class 042 — Scientific and technological services: Development of biological and pharmaceutical medicinal products for the treatment of diseases using a cell therapy platform; all of the foregoing not in connection with medical diagnostics, cancer diagnostics and cancer profiling
• Class 044 — Medical, beauty and agricultural services: Medical services related to the treatment and preparation of human cells; medical services, namely, immune cell therapy; medical services, namely, immune cell modification; medical services, namely, administration of immune cells; medical consulting related to immune cell therapy, all of the foregoing not in connection with medical diagnostics, cancer diagnostics and cancer profiling

Owner

• invIOs GmbH, Wien, AT
• invIOs GmbH, Wien, AT
• invIOs GmbH, Wien, AT

Prosecution history

• 31 Dec 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
• 31 Dec 2024 — REGISTERED-PRINCIPAL REGISTER
• 09 Dec 2024 — 1(B) BASIS DELETED; PROCEED TO REGISTRATION
• 07 May 2024 — NOTICE OF ALLOWANCE CANCELLED
• 09 Dec 2024 — REINSTATEMENT GRANTED - REQUEST TO DELETE 1(B) FILED
• 09 Dec 2024 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
• 09 Dec 2024 — ABANDONMENT - NO USE STATEMENT FILED
• 07 May 2024 — TEAS DELETE 1(B) BASIS RECEIVED
• 07 May 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
• 12 Mar 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
• 12 Mar 2024 — PUBLISHED FOR OPPOSITION
• 21 Feb 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
• 21 Feb 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
• 31 Jan 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
• 16 Jan 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED